Thomas M. Spitznagel

Sr. Vice President, Technical Operations at Macrogenics

Dr. Spitznagel, Senior Vice President, Technical Operations, joined us in 2013. He

has overall responsibility for biopharmaceutical development and manufacturing of

MacroGenics’ Fc-optimized monoclonal antibodies, DART® molecules, and

Antibody Drug Conjugates, as well as supply chain, CMC project management,

facilities and engineering. Prior to joining us, he was at Human Genome Sciences,

most recently serving as Vice President of BioPharmaceutical Development, where

he was responsible for oversight of Analytical Development, Formulation and Drug

Delivery, Purification Sciences, and Fermentation and Cell Culture Sciences. Prior

to joining HGS, Dr. Spitznagel was a Senior Scientist at Nabi from 1996-1998, and

a Staff Engineer at Genetics Institute from 1992-1996. Dr. Spitznagel earned his

BS in Chemical Engineering at M.I.T, and his Ph.D. in Chemical Engineering at the

University of California, Berkeley.